Gene expression changes in early phase of venom immunotherapy
Ontology highlight
ABSTRACT: Towards a better understanding of molecular processes underlying the acquisition of immune-tolerance during VIT (venom immunotherapy), we analysed genome-wide gene expression profiles of patients with severe hymenoptera venom allergy (HVA), who were analyzed prior to VIT and 12 months after the beginning of a VIT. The study also includes individuals withhout signs of HVA (as revealed by skin tests); beekepers and HVA patients sampled between 1st and 2nd month of VIT.
ORGANISM(S): Homo sapiens
PROVIDER: GSE92866 | GEO | 2017/01/21
SECONDARY ACCESSION(S): PRJNA358675
REPOSITORIES: GEO
ACCESS DATA